Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Current status and future perspectives in targeted therapy of NPM1-mutated AML.
Ranieri R, Pianigiani G, Sciabolacci S, Perriello VM, Marra A, Cardinali V, Pierangeli S, Milano F, Gionfriddo I, Brunetti L, Martelli MP, Falini B. Ranieri R, et al. Among authors: cardinali v. Leukemia. 2022 Oct;36(10):2351-2367. doi: 10.1038/s41375-022-01666-2. Epub 2022 Aug 25. Leukemia. 2022. PMID: 36008542 Free PMC article. Review.
High-Risk Clonal Hematopoiesis as the Origin of AITL and NPM1-Mutated AML.
Tiacci E, Venanzi A, Ascani S, Marra A, Cardinali V, Martino G, Codoni V, Schiavoni G, Martelli MP, Falini B. Tiacci E, et al. Among authors: cardinali v. N Engl J Med. 2018 Sep 6;379(10):981-984. doi: 10.1056/NEJMc1806413. N Engl J Med. 2018. PMID: 30184450 No abstract available.
Enasidenib and ivosidenib in AML.
Martelli MP, Martino G, Cardinali V, Falini B, Martinelli G, Cerchione C. Martelli MP, et al. Among authors: cardinali v. Minerva Med. 2020 Oct;111(5):411-426. doi: 10.23736/S0026-4806.20.07024-X. Epub 2020 Sep 21. Minerva Med. 2020. PMID: 32955829 Free article. Review.
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML.
Gionfriddo I, Brunetti L, Mezzasoma F, Milano F, Cardinali V, Ranieri R, Venanzi A, Pierangeli S, Vetro C, Spinozzi G, Dorillo E, Wu HC, Berthier C, Ciurnelli R, Griffin MJ, Jennings CE, Tiacci E, Sportoletti P, Falzetti F, de Thé H, Veal GJ, Martelli MP, Falini B. Gionfriddo I, et al. Among authors: cardinali v. Leukemia. 2021 Sep;35(9):2552-2562. doi: 10.1038/s41375-021-01192-7. Epub 2021 Mar 2. Leukemia. 2021. PMID: 33654209 Free PMC article. Clinical Trial.
Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML.
Martelli MP, Rossi R, Venanzi A, Meggendorfer M, Perriello VM, Martino G, Spinelli O, Ciurnelli R, Varasano E, Brunetti L, Ascani S, Quadalti C, Cardinali V, Mezzasoma F, Gionfriddo I, Milano F, Pacini R, Tabarrini A, Bigerna B, Albano F, Specchia G, Vetro C, Di Raimondo F, Annibali O, Avvisati G, Rambaldi A, Falzetti F, Tiacci E, Sportoletti P, Haferlach T, Haferlach C, Falini B. Martelli MP, et al. Among authors: cardinali v. Blood. 2021 Dec 23;138(25):2696-2701. doi: 10.1182/blood.2021012732. Blood. 2021. PMID: 34343258 Free PMC article.
Case Report: Contrasting BCL2 Upregulation With Venetoclax in a Case of Refractory Lymphomatoid Papulosis and Progressive Chronic Lymphocytic Leukemia.
Guarente V, Martino G, Dorillo E, De Falco F, Rompietti C, Sorcini D, Brogna M, Cardinali V, Ascani S, Marra A, Sportoletti P. Guarente V, et al. Among authors: cardinali v. Front Oncol. 2021 Sep 9;11:729106. doi: 10.3389/fonc.2021.729106. eCollection 2021. Front Oncol. 2021. PMID: 34568060 Free PMC article.
NPM1-mutated AML with starry sky pattern.
Falini B, Cardinali V, Brunetti L, Martelli MP. Falini B, et al. Among authors: cardinali v. Br J Haematol. 2023 Jul;202(1):8. doi: 10.1111/bjh.18808. Epub 2023 May 8. Br J Haematol. 2023. PMID: 37153969 No abstract available.
A venetoclax and azacitidine bridge-to-transplant strategy for NPM1-mutated acute myeloid leukaemia in molecular failure.
Sartor C, Brunetti L, Audisio E, Cignetti A, Zannoni L, Cristiano G, Nanni J, Ciruolo R, Zingarelli F, Ottaviani E, Patuelli A, Bandini L, Forte D, Sciabolacci S, Cardinali V, Papayannidis C, Cavo M, Martelli MP, Curti A. Sartor C, et al. Among authors: cardinali v. Br J Haematol. 2023 Aug;202(3):599-607. doi: 10.1111/bjh.18887. Epub 2023 May 24. Br J Haematol. 2023. PMID: 37226312
One disease, two faces: clonally-related AML and MPDCP with skin involvement.
Martino G, Cimino G, Caridi M, Perta G, Cardinali V, Sciabolacci S, Quintini M, Matteucci C, Venanzi A, Tiacci E, Ascani S, Mecucci C, Martelli MP. Martino G, et al. Among authors: cardinali v. Ann Hematol. 2023 Oct;102(10):2969-2971. doi: 10.1007/s00277-023-05377-1. Epub 2023 Jul 22. Ann Hematol. 2023. PMID: 37481474 No abstract available.
Blinatumomab Redirects Donor Lymphocytes against CD19+ Acute Lymphoblastic Leukemia without Relevant Bystander Alloreactivity after Haploidentical Hematopoietic Stem Cell Transplantation.
Mancusi A, Zorutti F, Ruggeri L, Bonato S, Tricarico S, Zei T, Iacucci Ostini R, Viglione V, Sembenico R, Sciabolacci S, Cardinali V, Martelli MF, Mecucci C, Carotti A, Martelli MP, Velardi A, Pierini A. Mancusi A, et al. Among authors: cardinali v. Int J Mol Sci. 2023 Nov 9;24(22):16105. doi: 10.3390/ijms242216105. Int J Mol Sci. 2023. PMID: 38003295 Free PMC article.
23 results